This brand name is authorized in Estonia.
The drug ADELPHANE-ESIDREX contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
8B1QWR724A - RESERPINE
|
2
|
UNII
1C2B1W91NK - DIHYDRALAZINE SULFATE
|
Dihydralazine is a member of phthalazines. |
|
3
|
UNII
0J48LPH2TH - HYDROCHLOROTHIAZIDE
|
Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC Group | Classification | |
---|---|---|
C02LA51 | Reserpine and diuretics, combinations with other drugs | C Cardiovascular system → C02 Antihypertensives → C02L Antihypertensives and diuretics in combination → C02LA Rauwolfia alkaloids and diuretics in combination |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
EE | Ravimiamet | 1469415, 1629312 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.